The global GLP-1 Receptor Agonist Market is estimated to be valued...

أضاف مادة جديدة أخرى

2023-08-25 09:40:28 -

The global GLP-1 Receptor Agonist Market is estimated to be valued at US$12,720.6 million in 2021 and is expected to exhibit a CAGR of 6.1% over the forecast period 2021-2028

GLP-1 receptor agonists are a class of medications used in the treatment of type 2 diabetes. They work by mimicking the action of GLP-1, a hormone that stimulates insulin release and lowers blood sugar levels. These medications have been shown to effectively control blood sugar levels, reduce weight, and lower the risk of cardiovascular events in patients with type 2 diabetes.Market DynamicsThe...

0 التعليقات 0 المشاركات 830 مشاهدة 0 معاينة